FDA grants Jacobus Pharma approval for rare disease drugAutoimmune Diseases, Children, Lambert-Eaton myasthenic syndrome (LEMS), Muscle Cells, Muscles, Nerve Cells, NervesJacobus Pharmaceutical Co. Inc. won U.S. approval for the first drug to treat children with Lambert-Eaton myasthenic syndrome, a rare autoimmune disorder. Read more May 6, 2019/by Reuters Health https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png 0 0 Reuters Health https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png Reuters Health2019-05-06 18:11:132019-05-07 12:57:56FDA grants Jacobus Pharma approval for rare disease drug
